[RGLS] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
23-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 9.86%
YoY- 4.72%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -7,824 -7,012 -7,139 -6,795 -7,551 -7,258 -6,718 10.68%
Tax -56 1 -45 1 -12 83 1 -
NP -7,824 -7,013 -7,094 -6,796 -7,539 -7,341 -6,719 10.67%
Tax Rate - - - - - - - -
Total Cost 7,824 7,013 7,094 6,796 7,539 7,341 6,719 10.67%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.40 -0.37 -0.42 -0.40 -0.50 -0.50 -0.46 -8.88%
EPS Diluted -0.40 -0.37 -0.42 -0.40 -0.50 -0.50 -0.46 -8.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.